Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vsee Health (VSEE) Enterprise Value (2023 - 2026)

Vsee Health filings provide 4 years of Enterprise Value readings, the most recent being -$291595.0 for Q2 2025.

  • On a quarterly basis, Enterprise Value changed N/A to -$291595.0 in Q2 2025 year-over-year; TTM through Jun 2025 was -$291595.0, a N/A change, with the full-year FY2024 number at -$326115.0, up 26.55% from a year prior.
  • Enterprise Value hit -$291595.0 in Q2 2025 for Vsee Health, up from -$326115.0 in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$507.0 in Q3 2023 to a low of -$444013.0 in Q4 2023.
  • Median Enterprise Value over the past 4 years was -$199296.5 (2022), compared with a mean of -$200014.8.
  • Biggest five-year swings in Enterprise Value: crashed 314.97% in 2023 and later rose 26.55% in 2024.
  • Vsee Health's Enterprise Value stood at -$106998.0 in 2022, then crashed by 314.97% to -$444013.0 in 2023, then rose by 26.55% to -$326115.0 in 2024, then rose by 10.59% to -$291595.0 in 2025.
  • The last three reported values for Enterprise Value were -$291595.0 (Q2 2025), -$326115.0 (Q4 2024), and -$444013.0 (Q4 2023) per Business Quant data.